FairJourney Biologics
  • Home
  • About us
    • History
    • Team
    • Credentials & Testimonials
  • Services
    • Antibody Discovery
    • Antibody Engineering
    • Antibody and Antigen Production
    • Antibody Functional Characterisation
    • Antibody Biophysical Characterisation
  • Technologies
    • Mammalian Display
    • Phage Display
    • Naïve Libraries
    • Triple Vector
  • Case Studies
  • Publications
  • News & Events
    • News
    • Events
  • Careers
    • Job Opportunities
    • Spontaneous Application
  • Portugal 2020
  • Contact Us
Select Page

FairJourney Biologics enter antibody discovery agreement with Pandion Therapeutics using novel discovery platforms

by aparada | Nov 23, 2020 | News FJB, News IONTAS, Press Release | 0 comments

Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research Porto, Portugal, Cambridge and London, UK, 23rd November 2020: FairJourney Biologics S.A...

IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squib

by aparada | Oct 13, 2020 | News FJB, News IONTAS, Press Release | 0 comments

IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...

IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency

by aparada | Sep 28, 2020 | News FJB, Press Release | 0 comments

IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency   · Panel of 15 potent antibodies selected that are optimally suited to clinical development and manufacturing · Monoclonal antibodies have the potential to both...

FairJourney Biologics Listed in Deloitte Fast 500

by aparada | Aug 10, 2020 | News FJB | 0 comments

We are pleased to announce that FairJourney Biologics has been named as one of the 500 fastest-growing EMEA tech companies in the Deloitte Technology Fast 500 with FairJourney ranking 293 recognising the company’s 439 percent growth. Full list can be found...

FairJourney Biologics joins forces with Iontas to create a global leader in outsourced antibody discovery services

by aparada | May 13, 2020 | News FJB | 0 comments

• FairJourney’s combination with Iontas creates a leading global antibody discovery Clinical Research Organisation (‘CRO’) with an international footprint • FairJourney’s unique antibody discovery libraries and service portfolio to be complemented by Iontas’...

Leading global antibody discovery companies FairJourney Biologics and Iontas announce partnership in search for SARS-CoV-2 treatment

by aparada | Apr 16, 2020 | News FJB | 0 comments

16 April 2020 • Bringing together complementary services and technology to allow faster identification of effective antibodies with a higher chance of success in development FairJourney Biologics (Porto, Portugal) and Iontas (Cambridge, UK) today announce a...
« Older Entries

Designed by Elegant Themes | Powered by WordPress